JGC
MDT icon

J. Goldman & Co’s Medtronic MDT Stock Holding History

J. Goldman & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,600
Closed -$203K – 289
2015
Q1 		$203K Sell
2,600
-46,900
-95% -$3.55M 0.01% 261
2014
Q4 		$3.57M Sell
49,500
-4,500
-8% -$313K 0.42% 74
2014
Q3 		$3.35M Buy
54,000
+36,200
+203% +$2.3M 0.2% 136
2014
Q2 		$1.14M Buy
+17,800
New +$1.08M 0.08% 180

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

J. Goldman & Co's MDT Position: Q2 2026 in Review

J. Goldman & Co sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,392 shares — an estimated $207K sold.

J. Goldman & Co first reported a position in MDT in Q3 2013 and held it in 6 quarters. The position peaked at $12.7M in Q4 2013. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • J. Goldman & Co reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • J. Goldman & Co sold 2,392 Medtronic shares in Q2 2026, an estimated $207K.
  • J. Goldman & Co first reported a position in Medtronic in Q3 2013 and held it in 6 quarters.
  • J. Goldman & Co's Medtronic position peaked at $12.7M in Q4 2013.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.